Intrinsiqq
Nu-Med Plus Inc. logo

Nu-Med Plus Inc.

NUMD

Compare
⚠ Showing the latest available close (Nov 19, 2026, 3 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$902K
EPS$0.00
P/E61.76
P/FCF–
EV/EBITDA–
FCF Yield–
Div. Yield–
Net Debt/FCF–
Nu-Med Plus Inc. intrinsic value
52-Week Range
$0.01$0.03

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$22K

▲ +17.8% YoY

Op. Margin

–

ROIC

-38.67%

▲ +11.4pp YoY

Cash Flow & Balance Sheet

FCF (FY)

-$48K

▼ -982.3% YoY

Op. Cash Flow (FY)

-$48K

▼ -982.3% YoY

Net Debt

$95K

Cash & Equiv.

$5K

Continue Research

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with NUMD

CompareIntrinsic value
AMIXAutonomix Medical Inc.
$0.89-14.32%20
NMTCNeuroOne Medical Technologies Corporation
$0.65-3.39%40
HRGNHarvard Apparatus Regenerative Technology Inc.
$1.90+4.11%10
PAVMPAVmed Inc.
$1.14-5.42%35
CODXCo-Diagnostics Inc.
$0.13-21.21%0
TNONTenon Medical Inc.
$0.90-9.01%40
LNSRLensar Inc.
$4.46-3.88%40
SSIISS Innovations International, Inc.
$1.27-0.78%30

Nu-Med Plus (NUMD) in three numbers

Quality score
4/100
Best check: share count change, 16.3%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
61.76
From the last twelve months of earnings.
Financials

Questions about Nu-Med Plus

Is Nu-Med Plus (NUMD) overvalued?

Nu-Med Plus trades at 61.76 times earnings. Intrinsiqq's fair value calculator has no opening value for NUMD, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.

Is Nu-Med Plus a high-quality business?

Nu-Med Plus scores 4 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 5 checks computed from SEC filings. Its best check is share count change at 16.3%. The Quality tab shows every check against its target.

Does Nu-Med Plus (NUMD) pay a dividend?

No. Nu-Med Plus (NUMD) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 14 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 19 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in NUMD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing NUMD

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.